4//SEC Filing
MENDLEIN JOHN 4
Accession 0001209191-22-036350
CIK 0001434316other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:42 PM ET
Size
7.1 KB
Accession
0001209191-22-036350
Insider Transaction Report
Form 4
MENDLEIN JOHN
Director
Transactions
- Award
Common Stock
2022-06-09+8,650→ 166,741 total - Award
Stock Option (Right to Buy)
2022-06-09+11,893→ 11,893 totalExercise: $23.48Exp: 2032-06-09→ Common Stock (11,893 underlying)
Footnotes (2)
- [F1]Award of restricted stock units that vest in full on the earlier of (i) June 9, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors.
- [F2]The shares subject to this option shall vest and become exercisable on the earlier of (i) June 9, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors.
Documents
Issuer
FATE THERAPEUTICS INC
CIK 0001434316
Entity typeother
Related Parties
1- filerCIK 0001238362
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 4:42 PM ET
- Size
- 7.1 KB